REF 5065, Kendall, Impad Rigid Sole Foot Cover, Regular Pair ,<12", Rx Only Non-Sterile

FDA Device Recall #Z-1612-2023 — Class II — April 14, 2023

Recall Summary

Recall Number Z-1612-2023
Classification Class II — Moderate risk
Date Initiated April 14, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Stryker Sustainability Solutions
Location Tempe, AZ
Product Type Devices
Quantity 50 units

Product Description

REF 5065, Kendall, Impad Rigid Sole Foot Cover, Regular Pair ,<12", Rx Only Non-Sterile

Reason for Recall

Through complaint surveillance, it was identified that reprocessed Deep vein thrombosis (DVT) Compression Sleeves may be mislabeled and/or mispackaged.

Distribution Pattern

US: WA OUS: None

Lot / Code Information

Lot # 0000157564, UDI-DI: 00885825013585

Other Recalls from Stryker Sustainability Solutions

Recall # Classification Product Date
Z-0490-2026 Class II HARMONIC FOCUS Shears + Adaptive Tissue Technol... Sep 24, 2025
Z-2689-2024 Class II Disposable 5 Lead Cable and Lead Wire System, 5... Jul 2, 2024
Z-2405-2024 Class II REF: 60-7070-005, Zimmer, Tourniquet Cuff 30" (... May 31, 2024
Z-2268-2024 Class II Stryker Sustainability Solutions, BW Lasso 2515... May 10, 2024
Z-2394-2023 Class II HoverMatt, 39" W x 78" L, REF: HM39SPU-B Jun 21, 2023

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.